Oral epidermal growth factor receptor tyrosine kinase inhibitor in tablet form for non-small cell lung cancer treatment. Purchased by cancer treatment centers for targeted therapy protocols. Provided by pharmaceutical suppliers to oncologists in specialized clinics.